Morgan Leigh Brown, M.D., Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cardiac Surgical Procedures | 23 | 2024 | 3627 | 2.440 |
Why?
|
| Heart Defects, Congenital | 11 | 2023 | 4671 | 1.380 |
Why?
|
| Aortic Coarctation | 3 | 2021 | 275 | 1.300 |
Why?
|
| Heart Ventricles | 9 | 2024 | 3807 | 1.230 |
Why?
|
| Anesthesia | 4 | 2022 | 1594 | 1.200 |
Why?
|
| Ebstein Anomaly | 4 | 2008 | 105 | 1.150 |
Why?
|
| Heart Valve Prosthesis | 7 | 2011 | 1462 | 1.120 |
Why?
|
| Fontan Procedure | 3 | 2022 | 796 | 1.060 |
Why?
|
| Aortic Valve | 7 | 2011 | 1955 | 0.910 |
Why?
|
| Anesthesia, General | 3 | 2022 | 1174 | 0.900 |
Why?
|
| Heart Valve Prosthesis Implantation | 11 | 2011 | 1553 | 0.890 |
Why?
|
| Intraoperative Complications | 3 | 2018 | 1165 | 0.850 |
Why?
|
| Postoperative Nausea and Vomiting | 2 | 2022 | 128 | 0.830 |
Why?
|
| Hypertension, Pulmonary | 3 | 2024 | 1578 | 0.770 |
Why?
|
| Heart-Assist Devices | 3 | 2019 | 1287 | 0.760 |
Why?
|
| Bioprosthesis | 3 | 2011 | 591 | 0.730 |
Why?
|
| Cardiomyopathy, Hypertrophic | 5 | 2010 | 1310 | 0.710 |
Why?
|
| Thoracic Surgery | 2 | 2023 | 722 | 0.680 |
Why?
|
| Thyroid Diseases | 1 | 2021 | 386 | 0.590 |
Why?
|
| Tachycardia | 1 | 2020 | 600 | 0.580 |
Why?
|
| Pulmonary Artery | 2 | 2020 | 1927 | 0.560 |
Why?
|
| Norwood Procedures | 1 | 2019 | 192 | 0.560 |
Why?
|
| Surgical Procedures, Operative | 3 | 2018 | 1922 | 0.550 |
Why?
|
| Catheters, Indwelling | 1 | 2019 | 426 | 0.540 |
Why?
|
| Williams Syndrome | 1 | 2018 | 194 | 0.520 |
Why?
|
| Catheter Ablation | 3 | 2020 | 2751 | 0.510 |
Why?
|
| Aortic Valve Insufficiency | 2 | 2010 | 576 | 0.500 |
Why?
|
| Catheterization, Peripheral | 1 | 2019 | 343 | 0.500 |
Why?
|
| Postoperative Complications | 11 | 2022 | 15631 | 0.450 |
Why?
|
| Catheterization, Central Venous | 1 | 2019 | 527 | 0.450 |
Why?
|
| Hypoplastic Left Heart Syndrome | 1 | 2019 | 594 | 0.440 |
Why?
|
| Airway Management | 1 | 2017 | 312 | 0.440 |
Why?
|
| Down Syndrome | 1 | 2021 | 901 | 0.430 |
Why?
|
| Pulmonary Valve | 1 | 2017 | 411 | 0.420 |
Why?
|
| Preoperative Care | 1 | 2021 | 2242 | 0.400 |
Why?
|
| Heart Valve Diseases | 3 | 2008 | 1027 | 0.380 |
Why?
|
| Tetralogy of Fallot | 1 | 2017 | 618 | 0.380 |
Why?
|
| Mitral Valve | 3 | 2010 | 1465 | 0.380 |
Why?
|
| Anesthesiology | 2 | 2022 | 1117 | 0.360 |
Why?
|
| Pain, Postoperative | 6 | 2024 | 1739 | 0.360 |
Why?
|
| Child | 22 | 2024 | 80153 | 0.350 |
Why?
|
| Aortic Valve Stenosis | 4 | 2011 | 2001 | 0.350 |
Why?
|
| Operating Room Information Systems | 1 | 2009 | 15 | 0.350 |
Why?
|
| Nitric Oxide | 1 | 2019 | 2135 | 0.340 |
Why?
|
| Heart Diseases | 2 | 2021 | 2781 | 0.340 |
Why?
|
| Mediastinitis | 1 | 2009 | 49 | 0.330 |
Why?
|
| Heart Valves | 1 | 2011 | 284 | 0.320 |
Why?
|
| Perioperative Care | 1 | 2017 | 1033 | 0.320 |
Why?
|
| Child, Preschool | 16 | 2024 | 42230 | 0.320 |
Why?
|
| Paraganglioma, Extra-Adrenal | 1 | 2008 | 45 | 0.310 |
Why?
|
| Data Mining | 2 | 2010 | 551 | 0.310 |
Why?
|
| Hypertrophy, Left Ventricular | 2 | 2010 | 851 | 0.310 |
Why?
|
| Retrospective Studies | 24 | 2024 | 80636 | 0.300 |
Why?
|
| Mitral Valve Insufficiency | 2 | 2009 | 1400 | 0.300 |
Why?
|
| Infant | 14 | 2024 | 36192 | 0.300 |
Why?
|
| Systole | 2 | 2009 | 936 | 0.300 |
Why?
|
| Mammary Arteries | 1 | 2008 | 81 | 0.300 |
Why?
|
| Atrial Septum | 1 | 2008 | 60 | 0.300 |
Why?
|
| Coronary Artery Bypass | 4 | 2011 | 2188 | 0.300 |
Why?
|
| Sternum | 1 | 2008 | 175 | 0.290 |
Why?
|
| Cardiovascular Surgical Procedures | 1 | 2008 | 189 | 0.290 |
Why?
|
| Survival Rate | 10 | 2021 | 12725 | 0.290 |
Why?
|
| Medical Records | 2 | 2013 | 1408 | 0.290 |
Why?
|
| Mediastinum | 1 | 2008 | 267 | 0.280 |
Why?
|
| Heart Septum | 1 | 2008 | 301 | 0.280 |
Why?
|
| Graft Occlusion, Vascular | 1 | 2010 | 537 | 0.280 |
Why?
|
| Personnel Staffing and Scheduling | 1 | 2011 | 495 | 0.280 |
Why?
|
| Humans | 64 | 2024 | 761504 | 0.280 |
Why?
|
| Treatment Outcome | 23 | 2024 | 64680 | 0.280 |
Why?
|
| Electronic Health Records | 2 | 2016 | 4811 | 0.260 |
Why?
|
| Pediatrics | 2 | 2022 | 3589 | 0.260 |
Why?
|
| Thrombosis | 3 | 2019 | 2942 | 0.260 |
Why?
|
| Mediastinal Neoplasms | 1 | 2008 | 401 | 0.250 |
Why?
|
| Nerve Block | 2 | 2024 | 706 | 0.250 |
Why?
|
| Societies, Medical | 3 | 2023 | 3905 | 0.250 |
Why?
|
| Aorta | 1 | 2013 | 2042 | 0.250 |
Why?
|
| Tricuspid Valve | 1 | 2008 | 410 | 0.250 |
Why?
|
| Arterial Occlusive Diseases | 1 | 2009 | 748 | 0.240 |
Why?
|
| Iatrogenic Disease | 1 | 2008 | 539 | 0.240 |
Why?
|
| Male | 40 | 2024 | 360804 | 0.240 |
Why?
|
| Aorta, Thoracic | 1 | 2010 | 1096 | 0.230 |
Why?
|
| Ventricular Pressure | 1 | 2024 | 210 | 0.220 |
Why?
|
| Female | 39 | 2024 | 392644 | 0.220 |
Why?
|
| Time Factors | 13 | 2024 | 39967 | 0.210 |
Why?
|
| Echocardiography | 4 | 2024 | 4989 | 0.200 |
Why?
|
| Ubiquitin-Conjugating Enzymes | 1 | 2002 | 200 | 0.190 |
Why?
|
| Schizosaccharomyces pombe Proteins | 1 | 2002 | 179 | 0.190 |
Why?
|
| Sarcoidosis | 1 | 2007 | 521 | 0.190 |
Why?
|
| Biomedical Research | 1 | 2016 | 3429 | 0.180 |
Why?
|
| Ventricular Dysfunction, Left | 2 | 2009 | 2118 | 0.180 |
Why?
|
| Adult | 24 | 2022 | 221177 | 0.180 |
Why?
|
| Quality Assurance, Health Care | 1 | 2011 | 2169 | 0.180 |
Why?
|
| Schizosaccharomyces | 1 | 2002 | 238 | 0.180 |
Why?
|
| Vascular Surgical Procedures | 1 | 2009 | 1489 | 0.180 |
Why?
|
| Databases as Topic | 3 | 2010 | 473 | 0.170 |
Why?
|
| Incidence | 6 | 2020 | 21353 | 0.170 |
Why?
|
| Professional Practice | 1 | 2022 | 313 | 0.170 |
Why?
|
| Reoperation | 4 | 2013 | 4303 | 0.170 |
Why?
|
| Follow-Up Studies | 9 | 2021 | 39106 | 0.170 |
Why?
|
| Patient Care Team | 1 | 2011 | 2521 | 0.170 |
Why?
|
| Coronary Angiography | 2 | 2008 | 4471 | 0.160 |
Why?
|
| Data Interpretation, Statistical | 1 | 2008 | 2691 | 0.150 |
Why?
|
| Fungal Proteins | 1 | 2002 | 910 | 0.150 |
Why?
|
| Pulmonary Circulation | 2 | 2019 | 737 | 0.150 |
Why?
|
| Adolescent | 12 | 2024 | 88319 | 0.150 |
Why?
|
| Analgesics, Opioid | 3 | 2024 | 3808 | 0.150 |
Why?
|
| Middle Aged | 21 | 2015 | 220895 | 0.150 |
Why?
|
| Aged | 19 | 2015 | 169289 | 0.150 |
Why?
|
| Catheters | 1 | 2021 | 427 | 0.150 |
Why?
|
| Vascular Patency | 3 | 2010 | 911 | 0.140 |
Why?
|
| Intraoperative Period | 2 | 2009 | 510 | 0.140 |
Why?
|
| Evidence-Based Medicine | 2 | 2010 | 3688 | 0.140 |
Why?
|
| Risk Assessment | 9 | 2015 | 23995 | 0.140 |
Why?
|
| Echocardiography, Transesophageal | 3 | 2008 | 1086 | 0.140 |
Why?
|
| Electrophysiology | 1 | 2020 | 1262 | 0.140 |
Why?
|
| Morphine | 1 | 2021 | 657 | 0.140 |
Why?
|
| Registries | 3 | 2010 | 8224 | 0.140 |
Why?
|
| Factor VIIa | 1 | 2017 | 103 | 0.140 |
Why?
|
| Survival Analysis | 5 | 2009 | 10090 | 0.130 |
Why?
|
| Palliative Care | 4 | 2019 | 3598 | 0.130 |
Why?
|
| Models, Theoretical | 1 | 2008 | 3575 | 0.130 |
Why?
|
| Patient Satisfaction | 1 | 2008 | 3461 | 0.130 |
Why?
|
| Vascular Resistance | 1 | 2019 | 930 | 0.130 |
Why?
|
| Administration, Inhalation | 1 | 2019 | 1157 | 0.130 |
Why?
|
| Length of Stay | 5 | 2022 | 6425 | 0.130 |
Why?
|
| Severity of Illness Index | 8 | 2010 | 15842 | 0.130 |
Why?
|
| DNA Replication | 1 | 2002 | 1418 | 0.130 |
Why?
|
| Cardiomyopathies | 1 | 2007 | 1964 | 0.120 |
Why?
|
| Vasoconstrictor Agents | 1 | 2018 | 654 | 0.120 |
Why?
|
| DNA Repair | 1 | 2002 | 2045 | 0.110 |
Why?
|
| Infant, Newborn | 4 | 2019 | 26198 | 0.110 |
Why?
|
| Probability | 2 | 2008 | 2477 | 0.100 |
Why?
|
| Research Design | 1 | 2008 | 6180 | 0.100 |
Why?
|
| Hemodynamics | 1 | 2022 | 4159 | 0.100 |
Why?
|
| Blood Transfusion | 1 | 2019 | 1298 | 0.100 |
Why?
|
| Ultrasonography | 3 | 2010 | 5972 | 0.100 |
Why?
|
| Aged, 80 and over | 8 | 2015 | 58976 | 0.100 |
Why?
|
| Stroke Volume | 4 | 2010 | 5496 | 0.100 |
Why?
|
| Minnesota | 2 | 2010 | 338 | 0.100 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2008 | 10209 | 0.090 |
Why?
|
| Young Adult | 5 | 2022 | 59243 | 0.090 |
Why?
|
| Axillary Vein | 1 | 2010 | 14 | 0.090 |
Why?
|
| Quality Control | 2 | 2010 | 832 | 0.090 |
Why?
|
| Operating Rooms | 2 | 2022 | 789 | 0.090 |
Why?
|
| Axillary Artery | 1 | 2010 | 47 | 0.090 |
Why?
|
| Poisson Distribution | 1 | 2011 | 504 | 0.090 |
Why?
|
| Cyanosis | 1 | 2010 | 82 | 0.090 |
Why?
|
| Swine | 2 | 2011 | 5915 | 0.090 |
Why?
|
| Forms and Records Control | 1 | 2009 | 158 | 0.080 |
Why?
|
| Prognosis | 5 | 2021 | 29625 | 0.080 |
Why?
|
| Sternotomy | 1 | 2009 | 128 | 0.080 |
Why?
|
| Cohort Studies | 5 | 2013 | 41487 | 0.080 |
Why?
|
| Echocardiography, Doppler | 2 | 2010 | 897 | 0.070 |
Why?
|
| Sampling Studies | 1 | 2009 | 615 | 0.070 |
Why?
|
| Heart Arrest | 1 | 2018 | 1514 | 0.070 |
Why?
|
| Databases, Factual | 1 | 2023 | 7967 | 0.070 |
Why?
|
| Chronic Disease | 1 | 2022 | 9318 | 0.070 |
Why?
|
| Balloon Occlusion | 1 | 2008 | 125 | 0.070 |
Why?
|
| Comorbidity | 2 | 2015 | 10508 | 0.070 |
Why?
|
| Arteriovenous Shunt, Surgical | 1 | 2010 | 292 | 0.070 |
Why?
|
| Risk Factors | 7 | 2016 | 74206 | 0.070 |
Why?
|
| Observation | 1 | 2008 | 310 | 0.070 |
Why?
|
| Hypertension | 3 | 2013 | 8540 | 0.070 |
Why?
|
| Thoracic Neoplasms | 1 | 2008 | 267 | 0.070 |
Why?
|
| Health Services for the Aged | 1 | 2008 | 259 | 0.070 |
Why?
|
| Ventricular Dysfunction | 1 | 2007 | 144 | 0.070 |
Why?
|
| Anastomosis, Surgical | 1 | 2009 | 983 | 0.060 |
Why?
|
| Respiration, Artificial | 1 | 2017 | 2628 | 0.060 |
Why?
|
| Cross-Sectional Studies | 2 | 2022 | 26125 | 0.060 |
Why?
|
| Catheterization | 1 | 2010 | 1428 | 0.060 |
Why?
|
| Peer Review, Research | 1 | 2008 | 340 | 0.060 |
Why?
|
| Multivariate Analysis | 2 | 2008 | 12059 | 0.060 |
Why?
|
| Thoracic Surgical Procedures | 1 | 2008 | 349 | 0.060 |
Why?
|
| Proportional Hazards Models | 2 | 2010 | 12463 | 0.060 |
Why?
|
| Ventricular Outflow Obstruction | 1 | 2006 | 261 | 0.060 |
Why?
|
| Cardiovascular Diseases | 1 | 2010 | 15500 | 0.060 |
Why?
|
| Predictive Value of Tests | 3 | 2010 | 15266 | 0.060 |
Why?
|
| Observer Variation | 1 | 2010 | 2606 | 0.060 |
Why?
|
| Waiting Lists | 1 | 2008 | 765 | 0.050 |
Why?
|
| Canada | 1 | 2008 | 2122 | 0.050 |
Why?
|
| United States | 6 | 2022 | 72334 | 0.050 |
Why?
|
| Exercise Tolerance | 1 | 2008 | 836 | 0.050 |
Why?
|
| Reproducibility of Results | 3 | 2010 | 20098 | 0.050 |
Why?
|
| Confidence Intervals | 1 | 2008 | 2927 | 0.050 |
Why?
|
| Hospitalization | 1 | 2022 | 10723 | 0.050 |
Why?
|
| Medical Records Systems, Computerized | 1 | 2008 | 1192 | 0.050 |
Why?
|
| Prosthesis Failure | 1 | 2007 | 1204 | 0.050 |
Why?
|
| Fibrosis | 1 | 2009 | 2049 | 0.050 |
Why?
|
| Prospective Studies | 5 | 2024 | 54425 | 0.050 |
Why?
|
| Morphine Derivatives | 1 | 2021 | 42 | 0.050 |
Why?
|
| Diabetic Angiopathies | 1 | 2007 | 803 | 0.050 |
Why?
|
| Two-Hybrid System Techniques | 1 | 2002 | 460 | 0.050 |
Why?
|
| Angioplasty, Balloon, Coronary | 1 | 2008 | 1725 | 0.050 |
Why?
|
| Creatinine | 1 | 2007 | 1899 | 0.050 |
Why?
|
| Ligases | 1 | 2002 | 333 | 0.050 |
Why?
|
| Clinical Protocols | 1 | 2007 | 1440 | 0.050 |
Why?
|
| Hospital Mortality | 2 | 2016 | 5294 | 0.050 |
Why?
|
| Program Evaluation | 1 | 2009 | 2495 | 0.050 |
Why?
|
| Ventricular Function, Right | 1 | 2024 | 617 | 0.040 |
Why?
|
| Blood Vessel Prosthesis Implantation | 1 | 2010 | 1428 | 0.040 |
Why?
|
| Disease-Free Survival | 1 | 2010 | 6814 | 0.040 |
Why?
|
| Gene Expression Regulation, Fungal | 1 | 2002 | 495 | 0.040 |
Why?
|
| Analysis of Variance | 1 | 2008 | 6228 | 0.040 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2010 | 6484 | 0.040 |
Why?
|
| Gene Library | 1 | 2002 | 1059 | 0.040 |
Why?
|
| Cardiac Imaging Techniques | 1 | 2022 | 267 | 0.040 |
Why?
|
| Patient Participation | 1 | 2008 | 1444 | 0.040 |
Why?
|
| Patient Selection | 2 | 2008 | 4244 | 0.040 |
Why?
|
| DNA, Complementary | 1 | 2002 | 1991 | 0.040 |
Why?
|
| Mutagenesis | 1 | 2002 | 1232 | 0.040 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 2002 | 2748 | 0.040 |
Why?
|
| DNA Primers | 1 | 2002 | 2819 | 0.040 |
Why?
|
| Cloning, Molecular | 1 | 2002 | 4174 | 0.040 |
Why?
|
| Circulatory Arrest, Deep Hypothermia Induced | 1 | 2017 | 82 | 0.030 |
Why?
|
| Critical Care | 2 | 2022 | 2696 | 0.030 |
Why?
|
| Pilot Projects | 1 | 2009 | 8631 | 0.030 |
Why?
|
| Ventricular Function, Left | 1 | 2009 | 3879 | 0.030 |
Why?
|
| Ambulatory Care | 1 | 2007 | 2775 | 0.030 |
Why?
|
| Logistic Models | 1 | 2010 | 13255 | 0.030 |
Why?
|
| Career Choice | 1 | 2022 | 756 | 0.030 |
Why?
|
| Health Status | 1 | 2008 | 4077 | 0.030 |
Why?
|
| Heart Transplantation | 1 | 2008 | 3233 | 0.030 |
Why?
|
| Coronary Disease | 1 | 2008 | 5914 | 0.030 |
Why?
|
| Pain Measurement | 1 | 2024 | 3550 | 0.030 |
Why?
|
| Sensitivity and Specificity | 1 | 2008 | 14666 | 0.030 |
Why?
|
| Polymerase Chain Reaction | 1 | 2002 | 6075 | 0.030 |
Why?
|
| Saccharomyces cerevisiae Proteins | 1 | 2002 | 1841 | 0.030 |
Why?
|
| Ubiquitin-Protein Ligases | 1 | 2002 | 1897 | 0.030 |
Why?
|
| Trans-Activators | 1 | 2002 | 2856 | 0.030 |
Why?
|
| DNA Damage | 1 | 2002 | 2446 | 0.030 |
Why?
|
| Cell Survival | 1 | 2002 | 5791 | 0.030 |
Why?
|
| Cardiopulmonary Bypass | 1 | 2017 | 1092 | 0.020 |
Why?
|
| Practice Guidelines as Topic | 1 | 2008 | 7390 | 0.020 |
Why?
|
| Amino Acid Sequence | 1 | 2002 | 13446 | 0.020 |
Why?
|
| Coronary Artery Disease | 1 | 2010 | 6403 | 0.020 |
Why?
|
| Heart Bypass, Right | 1 | 2010 | 75 | 0.020 |
Why?
|
| Molecular Sequence Data | 1 | 2002 | 17635 | 0.020 |
Why?
|
| Atrial Fibrillation | 1 | 2008 | 5127 | 0.020 |
Why?
|
| Propensity Score | 1 | 2017 | 1913 | 0.020 |
Why?
|
| Polycythemia | 1 | 2010 | 124 | 0.020 |
Why?
|
| Animals | 2 | 2011 | 168459 | 0.020 |
Why?
|
| Recombinant Proteins | 1 | 2017 | 6534 | 0.020 |
Why?
|
| Blood Flow Velocity | 1 | 2010 | 1371 | 0.020 |
Why?
|
| Pain | 1 | 2022 | 5073 | 0.020 |
Why?
|
| Quality of Life | 1 | 2008 | 13367 | 0.020 |
Why?
|
| Patient Readmission | 1 | 2019 | 3270 | 0.020 |
Why?
|
| Risk | 1 | 2017 | 9610 | 0.020 |
Why?
|
| Hemoglobins | 1 | 2010 | 1525 | 0.010 |
Why?
|
| Odds Ratio | 1 | 2016 | 9646 | 0.010 |
Why?
|
| Internship and Residency | 1 | 2022 | 5880 | 0.010 |
Why?
|
| Age Factors | 2 | 2008 | 18395 | 0.010 |
Why?
|
| Quality Indicators, Health Care | 1 | 2010 | 1792 | 0.010 |
Why?
|
| Cause of Death | 1 | 2010 | 3683 | 0.010 |
Why?
|
| Oxygen | 1 | 2010 | 4227 | 0.010 |
Why?
|
| Mutation | 1 | 2002 | 30052 | 0.010 |
Why?
|
| Sex Factors | 1 | 2007 | 10552 | 0.010 |
Why?
|
| Atherosclerosis | 1 | 2007 | 3408 | 0.010 |
Why?
|